Company Overview of Redwood Bioscience, Inc.
Redwood Bioscience, Inc. develops a protein-chemical engineering technology to produce antibody-drug conjugates and other semi-synthetic biotherapeutics. The company offers SMARTag site-specific protein modification and cytotoxin-linker technologies that enable the generation of homogenous bioconjugates engineered to enhance potency, safety, and stability. Its SMARTag platform provides precise payload positioning and defined stoichiometry of payload–protein ratios. The company was incorporated in 2008 and is based in Emeryville, California. As of October 2, 2014, Redwood Bioscience, Inc. operates as a subsidiary of Catalent Pharma Solutions, Inc.
5703 Hollis Street
Emeryville, CA 94608
Founded in 2008
Key Executives for Redwood Bioscience, Inc.
Similar Private Companies By Industry
|Pulmo BioTech, Inc.||United States|
|CP Meilland, LLC||United States|
|Batu Biologics, Inc.||United States|
|Heller Biotech International, Inc.||United States|
|Calypte Biomedical Corp.||United States|
Recent Private Companies Transactions
October 2, 2014
To contact Redwood Bioscience, Inc., please visit www.redwoodbioscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.